Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Cylexin phase II results announced

May 10, 1996

Zynaxis to develop Zyn-Linker form of paclitaxel for restenosis Rx

May 10, 1996

Cardioprotective activity of LU-51198 demonstrated in animal model

May 10, 1996

5-HT2 antagonists claimed by Toa Eiyo

May 10, 1996

Napp introduces novel diltiazem formulation in U.K.

May 10, 1996

New antihypertensive/diuretic isolated from natural source

May 10, 1996

PD-161721: A new tool for the study of ET receptors

May 10, 1996

LU-135252 improves pulmonary hypertension in rats

May 10, 1996

Endothelin antagonists reported by Bristol-Myers Squibb

May 10, 1996

Ciba-Geigy reveals renin inhibitors

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Lilly shifts from obesity to narcolepsy with $7.8B Centessa buy
BioWorld
Eli Lilly and Co. plans to buy Centessa Pharmaceuticals plc for $6.3 billion in up-front cash and another potential $1.5 billion through contingent value rights,...